180 related articles for article (PubMed ID: 12686159)
1. The inhibition of semicarbazide-sensitive amine oxidase by aminohexoses.
O'Sullivan J; O'Sullivan M; Tipton KF; Unzeta M; Del Mar Hernandez M; Davey GP
Biochim Biophys Acta; 2003 Apr; 1647(1-2):367-71. PubMed ID: 12686159
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen peroxide derived from amine oxidation mediates the interaction between aminosugars and semicarbazide-sensitive amine oxidase.
O'Sullivan J; Davey G; O'Sullivan M; Tipton KF
J Neural Transm (Vienna); 2007; 114(6):751-6. PubMed ID: 17401531
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
Wang SH; Yu TY; Tsai FC; Weston CJ; Lin MS; Hung CS; Kao HL; Li YI; Solé M; Unzeta M; Chen YL; Chuang LM; Li HY
Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075
[TBL] [Abstract][Full Text] [Related]
4. L-lysine as a recognition molecule for the VAP-1 function of SSAO.
Olivieri A; Tipton K; O'Sullivan J
J Neural Transm (Vienna); 2007; 114(6):747-9. PubMed ID: 17393063
[TBL] [Abstract][Full Text] [Related]
5. Interaction of L-lysine and soluble elastin with the semicarbazide-sensitive amine oxidase in the context of its vascular-adhesion and tissue maturation functions.
Olivieri A; O'Sullivan J; Fortuny LR; Vives IL; Tipton KF
Biochim Biophys Acta; 2010 Apr; 1804(4):941-7. PubMed ID: 20079884
[TBL] [Abstract][Full Text] [Related]
6. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia.
Sun P; Solé M; Unzeta M
Cerebrovasc Dis; 2014; 37(3):171-80. PubMed ID: 24503888
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of bovine lung semicarbazide-sensitive amine oxidase (SSAO) by some hydrazine derivatives.
Lizcano JM; Fernández de Arriba A; Tipton KF; Unzeta M
Biochem Pharmacol; 1996 Jul; 52(2):187-95. PubMed ID: 8694842
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
[TBL] [Abstract][Full Text] [Related]
9. Prolonged treatment with aminoguanidine strongly inhibits adipocyte semicarbazide-sensitive amine oxidase and slightly reduces fat deposition in obese Zucker rats.
Prévot D; Soltesz Z; Abello V; Wanecq E; Valet P; Unzeta M; Carpéné C
Pharmacol Res; 2007 Jul; 56(1):70-9. PubMed ID: 17548204
[TBL] [Abstract][Full Text] [Related]
10. Several aspects on the amine oxidation by semicarbazide-sensitive amine oxidase (SSAO) from bovine lung.
Lizcano JM; Fernandez de Arriba A; Lyles GA; Unzeta M
J Neural Transm Suppl; 1994; 41():415-20. PubMed ID: 7931259
[TBL] [Abstract][Full Text] [Related]
11. Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.
Carpéné C; Bizou M; Tréguer K; Hasnaoui M; Grès S
J Physiol Biochem; 2015 Sep; 71(3):487-96. PubMed ID: 25572340
[TBL] [Abstract][Full Text] [Related]
12. Soluble Vascular Adhesion Protein-1 Mediates Spermine Oxidation as Semicarbazide-Sensitive Amine Oxidase: Possible Role in Proliferative Diabetic Retinopathy.
Murata M; Noda K; Kawasaki A; Yoshida S; Dong Y; Saito M; Dong Z; Ando R; Mori S; Saito W; Kanda A; Ishida S
Curr Eye Res; 2017 Dec; 42(12):1674-1683. PubMed ID: 28937866
[TBL] [Abstract][Full Text] [Related]
13. Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.
Carpéné C; Abello V; Iffiú-Soltész Z; Mercier N; Fève B; Valet P
Pharmacol Res; 2008 Jun; 57(6):426-34. PubMed ID: 18539478
[TBL] [Abstract][Full Text] [Related]
14. Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model.
Wong M; Saad S; Zhang J; Gross S; Jarolimek W; Schilter H; Chen JA; Gill AJ; Pollock CA; Wong MG
Am J Physiol Renal Physiol; 2014 Oct; 307(8):F908-16. PubMed ID: 25143459
[TBL] [Abstract][Full Text] [Related]
15. Physiological and pathological implications of semicarbazide-sensitive amine oxidase.
Yu PH; Wright S; Fan EH; Lun ZR; Gubisne-Harberle D
Biochim Biophys Acta; 2003 Apr; 1647(1-2):193-9. PubMed ID: 12686132
[TBL] [Abstract][Full Text] [Related]
16. A structure-activity study to identify novel and efficient substrates of the human semicarbazide-sensitive amine oxidase/VAP-1 enzyme.
Bonaiuto E; Lunelli M; Scarpa M; Vettor R; Milan G; Di Paolo ML
Biochimie; 2010 Jul; 92(7):858-68. PubMed ID: 20298739
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of semicarbazide-sensitive amine oxidase induces the phenotypic switch of smooth muscle cells and aggravates the development of atherosclerotic lesions.
Zhang M; Liu L; Zhi F; Niu P; Yang M; Zhu X; Diao Y; Li Y; Wang J; Zhao Y
Atherosclerosis; 2016 Jun; 249():76-82. PubMed ID: 27065245
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of semicarbazide-sensitive amine oxidase from porcine aorta.
Tipnis UR; Tao M; Boor PJ
Cell Mol Biol (Noisy-le-grand); 1992; 38(5-6):575-84. PubMed ID: 1483111
[TBL] [Abstract][Full Text] [Related]
19. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
[TBL] [Abstract][Full Text] [Related]
20. Semicarbazide-sensitive amine oxidase activation promotes adipose conversion of 3T3-L1 cells.
Mercier N; Moldes M; El Hadri K; Fève B
Biochem J; 2001 Sep; 358(Pt 2):335-42. PubMed ID: 11513731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]